Ledger.Open graph →
SEC Form D · Amendment · filed March 9, 2017

Remiges BioPharma Fund, LP

Offering
$80.0M
Sold
$80.0M
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
CAMBRIDGE, MA
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Remiges Biopharma Fund Gp, Inc · CAMBRIDGE, MAExecRemiges Biopharma Fund Gp, Inc · SCARSDALE, NYExecWalter Olesiak · CAMBRIDGE, MAExec · DirectorTaro Inaba · Norwood, MADirectorRemiges Biopharma Fund Gp, Inc · SCARSDALE, NYExecWalter Olesiak · CAMBRIDGE, MAExec · DirectorTaro Inaba · Mountain View, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗